Stock Chart

BHC

$5.80 +1.22%
Score: 62.1 HOLD
LEAPs: SELL $5
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $5
Premium: $1.12
Expiry: Jan 15, 2027
Target: $5
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 1.72x (vs SPY: 1.7x | vs QQQ: 1.7x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 02, 2026
Bear Flag Bearish scenario quality 78/100
Setup invalidates on a close above $5.89 · pole −21% — no price target (measured-move targets failed our backtest for flags/pennants)
Historically breaks down 69% of the time (n=379) — the only flag with real bearish follow-through. Measured-move targets failed our backtest — none shown.
Pattern detection is automated and probabilistic — a scenario map for levels, not a buy/sell signal. Rails, projected path and invalidation level are drawn on the chart below.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About BHC - Bausch Health Companies Inc

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Key Statistics

Market Cap $2B

This BHC stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track BHC's price movements with trendlines, gamma walls, and key support/resistance levels.